First Allied Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

First Allied Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-274	Closed	-$15K	–	1489
2019 Q3	$15K	Buy	+274	New	+$15.7K	﹤0.01%	1499
2018 Q1	–	Sell	-313	Closed	-$18K	–	1391
2017 Q4	$18K	Buy	+313	New	+$17.9K	﹤0.01%	1410
2016 Q2	–	Sell	-4,860	Closed	-$281K	–	1079
2016 Q1	$281K	Sell	4,860 -2,497	-34%	-$148K	0.02%	764
2015 Q4	$487K	Buy	7,357 +2,708	+58%	+$175K	0.03%	588
2015 Q3	$291K	Buy	+4,649	New	+$327K	0.02%	747

Other funds holding PPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

First Allied Advisory Services's PPH Position: Q4 2019 in Review

First Allied Advisory Services sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2019, closing a stake of 274 shares — an estimated $15K sold.

First Allied Advisory Services first reported a position in PPH in Q3 2015 and held it in 5 quarters. The position peaked at $487K in Q4 2015. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2019.

First Allied Advisory Services reported no remaining VanEck Pharmaceutical ETF position as of Q4 2019 after selling out during the quarter.
First Allied Advisory Services sold 274 VanEck Pharmaceutical ETF shares in Q4 2019, an estimated $15K.
First Allied Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q3 2015 and held it in 5 quarters.
First Allied Advisory Services's VanEck Pharmaceutical ETF position peaked at $487K in Q4 2015.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2019.

Based on First Allied Advisory Services's 13F filing for Q4 2019, filed 10 Feb 2020.